ArticleFrontiers in immunology2025

Case Report: The combination of upadacitinib and adalimumab in the treatment of refractory ankylosing spondylitis.

Jiajia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.